Search Results for LIL

August 27th, 2026

Luis Enrique stresses importance of PSG squad as Dembele gets time to rest

Paris St Germain coach Luis Enrique will continue his squad rotation as the capital club again seek to dominate domestically and in Europe, with players who featured at the World C...

August 12th, 2026

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide

Eli Lilly on Wednesday said it ‌had filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide, es...

August 6th, 2026

Lilly, Novo defeat antitrust lawsuit over GLP‑1 drug market

Eli Lilly and Novo Nordisk have persuaded a U.S. federal judge to dismiss a lawsuit by a compound drug maker that accused the pharmaceutical giants of illegally blocking access to...

August 5th, 2026

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Eli Lilly and Co posted better-than-expected quarterly results and ‌raised its full-year revenue forecast on Wednesday, banking on sustained demand for its blockbuster GLP-1 weight...

August 3rd, 2026

Eli Lilly to offer early access to next-gen obesity drug to some patients

Eli Lilly said on Monday it would allow a limited number of patients to have early access to its experimental obesity drug, ‌retatrutide, before its U.S. FDA approval.

July 30th, 2026

Eli Lilly is pharma’s latest victim of success

As the $1 trln drugmaker’s smash-hit obesity treatments shrink waistlines, its cashflow and valuation are swelling. Gilead, Moderna and Pfizer show ⁠how hard it is to put such a...

July 30th, 2026

Lilly, Resilience to invest $750 million in US drug manufacturing expansion

Drugmaker Eli Lilly and privately held contract manufacturer Resilience will invest $750 million to expand pharmaceutical manufacturing capacity in the U.S. and strengthen the dom...

July 24th, 2026

Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads

Novo Nordisk said on Friday it is seeking ‌a preliminary U.S. court injunction to immediately block obesity and diabetes drug advertisements by Eli Lilly .

July 23rd, 2026

Lilly announces more next-gen obesity drug data, plans Q1 2027 FDA application

Eli Lilly ‌on Thursday said two more Phase 3 trials of its experimental obesity drug retatrutide showed positive results and it plans to submit an application to the U.S. Food and ...

July 21st, 2026

Novo Nordisk sues Eli Lilly, accusing it of false advertising

Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform Novo's ‌dru...

June 8th, 2026

Lilly shares jump as analysts see retatrutide data extending obesity market edge

Eli Lilly shares jumped 4% premarket on Monday, driven by compelling new data for its next-generation obesity drug, retatrutide, with analysts and investors expecting it to extend...

June 3rd, 2026

Lilly to halve planned €2.3 billion investment in Germany, CEO tells newspaper

Eli Lilly will halve its originally planned investment of €2.3 ‌billion ($2.67 billion) in Germany, CEO Dave Ricks told the Handelsblatt business daily.

June 3rd, 2026

Lilly gains license for Ascidian's gene-editing tech to develop kidney disease drugs

Ascidian Therapeutics said on Wednesday it has signed a licensing deal for its gene-editing technology with pharma major Eli Lilly , worth up to $1.9 billion, to develop new thera...

May 13th, 2026

Eli Lilly launches Alzheimer's drug Donanemab in India

U.S.-based drugmaker Eli Lilly on Wednesday launched its Alzheimer's drug Lormalzi, also known as Donanemab, in ‌India.

May 6th, 2026

Lilly commits additional $4.5 billion in Indiana manufacturing sites

Eli Lilly said on Wednesday it would invest $4.5 billion more across two of its three manufacturing sites in Indiana, bringing the U.S. drugmaker's total capital expansion commitm...

April 29th, 2026

Eli Lilly investors are eager for Foundayo insight after early launch data

Eli Lilly investors will be searching for something they won't find in any first-quarter financial figures reported on Thursday: insight into the launch of weight-loss pill Founda...

April 9th, 2026

Amazon to stock Lilly's new weight-loss pill at US kiosks, offer same-day delivery

Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's primary care clinics and offer same-day delive...

April 1st, 2026

Lilly gains after FDA approves weight-loss pill, sizing down investor doubts

Eli Lilly shares jumped nearly 6% on Wednesday after the U.S. Food and Drug Administration approved its weight-loss pill, Foundayo, marking a significant milestone in the drugmaker...

March 12th, 2026

Watkins goal earns Villa win at Lille, Bologna and Roma draw

Aston Villa came away from Lille with a 1-0 win thanks to Ollie Watkins' goal in the first leg of their Europa League last-16 tie on Thursday, while Bologna and AS Roma ‌played ou...

February 26th, 2026

Eli Lilly's weight-loss pill shows higher side effects than Novo rival in diabetes trial

Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment discontinuations than Novo Nordisk's oral semaglutide in a head-to-head diabetes tri...

CYCLICAL CONSUMER GOODS	-1.09%
NON-CYCLICAL CONSUMER GOODS	-1.38%
TECHNOLOGY	+3.16%
UTILITIES	-0.76%